An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells

• Published in: PloS one 2017-06, Vol.12 (6), p.e0177861-e0177861
• Main Authors: Azeem, Waqas, Hellem, Margrete Reime, Olsen, Jan Roger, Hua, Yaping, Marvyin, Kristo, Qu, Yi, Lin, Biaoyang, Ke, Xisong, Øyan, Anne Margrete, Kalland, Karl-Henning
• Format: Article
• Language: English
• Subjects: 17β-Estradiol; Activation; Activation analysis; Amplification; Androgen receptors; Androgens; Assaying; Benign; Biology and Life Sciences; Biotechnology; Cancer; Castration; Cell Line; Cytometry; Depletion; Deprivation; Dexamethasone; Differentiation; DNA methylation; Effectiveness; Flow cytometry; Fluorescence; Fluorescence microscopy; Gene expression; Gene sequencing; Genes; Genes, Reporter; Green Fluorescent Proteins - genetics; Humans; Inhibitors; Kinases; Localization; Luminescence; Male; Medicine and Health Sciences; Mesenchyme; Microscopy; Mutation; Offspring; Progeny; Progesterone; Promoters; Prostate - cytology; Prostate - physiology; Prostate cancer; Receptors, Androgen - genetics; Receptors, Androgen - physiology; Research and Analysis Methods; Subpopulations; Telomerase reverse transcriptase; Therapeutics; Therapy; Transcription factors; Transfection; Transit
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0177861

The androgen receptor (AR) transcription factor plays a key role in the development and progression of prostate cancer, as is evident from the efficacy of androgen-deprivation therapy, AR is also the most frequently mutated gene, in castration resistant prostate cancer (CRPC). AR has therefore become an even more attractive therapeutic target in aggressive and disseminated prostate cancer. To investigate mechanisms of AR and AR target gene activation in different subpopulations of prostate cancer cells, a toolkit of AR expressor and androgen response element (ARE) reporter vectors were developed. Three ARE reporter vectors were constructed with different ARE consensus sequences in promoters linked to either fluorescence or luciferase reporter genes in lentiviral vector backbones. Cell lines transduced with the different vectors expressed the reporters in an androgen-dependent way according to fluorescence microscopy, flow cytometry and multi-well fluorescent and luminescence assays. Interestingly, the background reporter activity in androgen-depleted medium was significantly higher in LNCaP cells compared to the prostate transit amplifying epithelial cell lines, EP156T-AR and 957E/hTERT-AR with exogenous AR. The androgen-induced signal to background was much higher in the latter benign prostate cells than in LNCaP cells. Androgen-independent nuclear localization of AR was seen in LNCaP cells and reduced ARE-signaling was seen following treatment with abiraterone, an androgen synthesis inhibitor. The ARE reporter activity was significantly stronger when stimulated by androgens than by β-estradiol, progesterone and dexamethasone in all tested cell types. Finally, no androgen-induced ARE reporter activity was observed in tumorigenic mesenchymal progeny cells of EP156T cells following epithelial to mesenchymal transition. This underscores the observation that expression of the classical luminal differentiation transcriptome is restricted in mesenchymal type cells with or without AR expression, and presence of androgen.